Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson’s disease

Levodopa-induced dyskinesia (LID) is a common motor complication in patients with Parkinson’s disease on chronic levodopa therapy. The management of LID is important as dyskinesia can be disabling and impair quality of life. Currently, there are limited treatment options for the medical management o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Vibhash D, Lyons, Kelly E, Pahwa, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905495/
https://www.ncbi.nlm.nih.gov/pubmed/29695911
http://dx.doi.org/10.2147/TCRM.S144481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905495/
https://www.ncbi.nlm.nih.gov/pubmed/29695911
http://dx.doi.org/10.2147/TCRM.S144481

Ejemplares similares